Searched for
PHARMA TARIFFS EXEMPTION
Trump pushes pharma tariffs, but exemptions limit impactThe United States has introduced tariffs on branded drug imports. However, many exemptions will limit their effect. Companies investing in ...- Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocksThe US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...
- Trump's 100% tariff on patented drugs has limited impact on Indian pharma, rising protectionism a concern: Syngene MDThe recent decision by US President Donald Trump to impose a 100 per cent tariff on patented pharmaceutical imports to US is unlikely to ca...
- India largely shielded from US tariffs on patented drugs due to generic export strength: GTRINew US tariffs on patented drugs will not significantly impact India. The country mainly exports affordable generic medicines to America. T...
- Pharma calls in sick after Trump’s 100% tariff threatPharma stocks fell Thursday after reports of US President Donald Trump mulling 100% tariffs on imported branded and patented medicine maker...
- Tariff therapy: Trump nudges pharma cos to make drugs in US or face 100% tariffAmerica is set to impose hefty 100% tariffs on imported medicines. This move targets drug companies that do not agree to government pricing...
- Sun Pharma most exposed Indian company to Trump's new tariff threat, warns JefferiesIndian drug maker Sun Pharma faces significant exposure to potential US tariffs on medicines. Global brokerage Jefferies warns that while g...
- Tariff threat ain't over yet! Sun Pharma, other pharma stocks plunge up to 6%Pharma stocks fell after reports that the Trump administration may impose tariffs—potentially up to 100%—on drugmakers not ensuring low pri...
- Budget 2026: Customs duty waiver likely for SEZ-made drugs sold locallyIndia may soon waive customs duty on medicines produced in special economic zones for local sale. This move aims to reduce costs and increa...
- Pharma Index Down 2%, but Selloff could be an 'Exaggeration'Nifty's Pharma index saw a decline after US President Trump announced a 100 percent tariff on branded drugs from October 1. Analysts noted ...
- Explained: What Dr Trump’s 100% bitter tariff pill means for India’s $10 billion pharma export machineThe US has imposed a 100% tariff on branded and patented pharmaceuticals, targeting imports from India’s $10 billion export industry. While...
- Pharma exporters expect Trump to act benevolently to themIndian drug makers, heavily reliant on the US market, face potential challenges due to President Trump's proposed 25% reciprocal tariff on ...
- Pharma stocks in focus as Trump signals tariffs on imported medicinesPresident Trump announced potential tariffs on imported pharmaceuticals, impacting countries like India, a major supplier to the US drug ma...
- Trump tariff hike hits Dalal Street: 4 sectors facing the biggest impact, global brokerages decodeThe Trump administration's 26% tariff on Indian imports has led to significant market reactions and economic concerns. Pharmaceuticals rema...
- No chill, just pills! Pharma stocks slide up to 8% as Trump does yes-no-yes on tariffShares of Indian pharma companies, including Aurobindo Pharma, Laurus Labs, IPCA Labs, and Lupin, fell up to 8% after U.S. President Donald...
- Pharma's exemption from reciprocal tariffs underscores generic medicines' critical role globallyThe US Administration has exempted pharmaceuticals from reciprocal tariffs, highlighting the significance of affordable, life-saving generi...
- Pharma stocks gain on tariff exemption in the USShares of Indian pharmaceutical companies surged on Thursday after the US exempted the sector from new trade tariffs. The Nifty Pharma inde...
- T-Rx: Indian pharma majors breathe easy as US spares sector from reciprocal tariffsLarge Indian drug manufacturers experienced relief as President Trump's administration decided against imposing expected reciprocal tariffs...
- Gland Pharma, Aurobindo, Lupin, and other pharma stocks surge up to 14% as Trump spares sector from new tariffsShares of Indian pharma companies with significant US exposure surged by up to 14% after President Trump refrained from imposing new tariff...
- Winners and Losers: Check which stocks could get impacted the most by Trump's tariff strikeMost experts believe the market will face short-term volatility, but the long-term structural outlook remains strong. Tariffs imposed acros...
Load More
